FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108144416> ?p ?o ?g. }

• W2108144416 endingPage "161" @default.
• W2108144416 startingPage "153" @default.
• W2108144416 abstract "Panobinostat, a potent pan-deacetylase inhibitor, improved progression-free survival (PFS) in patients with relapsed and refractory multiple myeloma when combined with bortezomib and dexamethasone in a phase 3 trial, PANORAMA-1. This study aims to explore exposure-response relationship for panobinostat in this combination in a phase 1 trial, B2207 and contrast with data from historical single-agent studies.Panobinostat plasma concentration-time profiles were obtained in patients from PANORAMA-1 (n = 12) and B2207 (n = 12) trials. Overall response rates (ORR) and major adverse events (AE) by panobinostat exposure were investigated in the B2207 trial. Panobinostat PK data from combination trials were contrasted with data from single-agent studies.At maximum tolerated dose (MTD), the geometric mean of panobinostat area under curve from 0 to 24 h (AUC0-24) was 47.5 ng h/mL (77 % CV), and maximum plasma concentration (Cmax) was 8.1 ng/mL (90 % CV). These values were comparable with exposure data obtained in PANORAMA-1, but were 20 % lower than those without dexamethasone, and ∼ 50 % lower from single-agent trials, likely due to enzyme induction by dexamethasone. Higher levels of panobinostat exposure were associated with higher response rates and higher incidences of diarrhea and thrombocytopenia.Apparent panobinostat exposure-AE and exposure-ORR relationships were observed when combined with bortezomib and dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma. The addition of dexamethasone facilitated best response even though plasma exposure of panobinostat was reduced. Combination with a strong enzyme inducer should be avoided in future trials to prevent further reduction of panobinostat exposure." @default.
• W2108144416 created "2016-06-24" @default.
• W2108144416 creator A5001816724 @default.
• W2108144416 creator A5013980586 @default.
• W2108144416 creator A5014431889 @default.
• W2108144416 creator A5021482668 @default.
• W2108144416 creator A5024474361 @default.
• W2108144416 creator A5034186877 @default.
• W2108144416 creator A5050035595 @default.
• W2108144416 creator A5073829136 @default.
• W2108144416 creator A5084664308 @default.
• W2108144416 creator A5090196613 @default.
• W2108144416 date "2015-10-22" @default.
• W2108144416 modified "2023-09-23" @default.
• W2108144416 title "Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma" @default.
• W2108144416 cites W1887243203 @default.
• W2108144416 cites W1981563918 @default.
• W2108144416 cites W1981797192 @default.
• W2108144416 cites W1983770251 @default.
• W2108144416 cites W1986235688 @default.
• W2108144416 cites W1988473759 @default.
• W2108144416 cites W1989429100 @default.
• W2108144416 cites W1991086228 @default.
• W2108144416 cites W2028919540 @default.
• W2108144416 cites W2028985159 @default.
• W2108144416 cites W2032395096 @default.
• W2108144416 cites W2072278069 @default.
• W2108144416 cites W2073858771 @default.
• W2108144416 cites W2086696240 @default.
• W2108144416 cites W2093255555 @default.
• W2108144416 cites W2096367061 @default.
• W2108144416 cites W2126441523 @default.
• W2108144416 cites W2132880072 @default.
• W2108144416 cites W2146816088 @default.
• W2108144416 cites W2149340130 @default.
• W2108144416 cites W2169183166 @default.
• W2108144416 cites W2171585059 @default.
• W2108144416 cites W2287394442 @default.
• W2108144416 cites W2578566804 @default.
• W2108144416 cites W4256116084 @default.
• W2108144416 doi "https://doi.org/10.1007/s00228-015-1967-z" @default.
• W2108144416 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4713719" @default.
• W2108144416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26494130" @default.
• W2108144416 hasPublicationYear "2015" @default.
• W2108144416 type Work @default.
• W2108144416 sameAs 2108144416 @default.
• W2108144416 citedByCount "20" @default.
• W2108144416 countsByYear W21081444162016 @default.
• W2108144416 countsByYear W21081444162017 @default.
• W2108144416 countsByYear W21081444162019 @default.
• W2108144416 countsByYear W21081444162020 @default.
• W2108144416 countsByYear W21081444162021 @default.
• W2108144416 countsByYear W21081444162022 @default.
• W2108144416 countsByYear W21081444162023 @default.
• W2108144416 crossrefType "journal-article" @default.
• W2108144416 hasAuthorship W2108144416A5001816724 @default.
• W2108144416 hasAuthorship W2108144416A5013980586 @default.
• W2108144416 hasAuthorship W2108144416A5014431889 @default.
• W2108144416 hasAuthorship W2108144416A5021482668 @default.
• W2108144416 hasAuthorship W2108144416A5024474361 @default.
• W2108144416 hasAuthorship W2108144416A5034186877 @default.
• W2108144416 hasAuthorship W2108144416A5050035595 @default.
• W2108144416 hasAuthorship W2108144416A5073829136 @default.
• W2108144416 hasAuthorship W2108144416A5084664308 @default.
• W2108144416 hasAuthorship W2108144416A5090196613 @default.
• W2108144416 hasBestOaLocation W21081444161 @default.
• W2108144416 hasConcept C104317684 @default.
• W2108144416 hasConcept C112705442 @default.
• W2108144416 hasConcept C126322002 @default.
• W2108144416 hasConcept C143998085 @default.
• W2108144416 hasConcept C185592680 @default.
• W2108144416 hasConcept C197934379 @default.
• W2108144416 hasConcept C2776364478 @default.
• W2108144416 hasConcept C2777478702 @default.
• W2108144416 hasConcept C2778305200 @default.
• W2108144416 hasConcept C2780225316 @default.
• W2108144416 hasConcept C2780401358 @default.
• W2108144416 hasConcept C535046627 @default.
• W2108144416 hasConcept C55493867 @default.
• W2108144416 hasConcept C64927066 @default.
• W2108144416 hasConcept C71924100 @default.
• W2108144416 hasConcept C98274493 @default.
• W2108144416 hasConceptScore W2108144416C104317684 @default.
• W2108144416 hasConceptScore W2108144416C112705442 @default.
• W2108144416 hasConceptScore W2108144416C126322002 @default.
• W2108144416 hasConceptScore W2108144416C143998085 @default.
• W2108144416 hasConceptScore W2108144416C185592680 @default.
• W2108144416 hasConceptScore W2108144416C197934379 @default.
• W2108144416 hasConceptScore W2108144416C2776364478 @default.
• W2108144416 hasConceptScore W2108144416C2777478702 @default.
• W2108144416 hasConceptScore W2108144416C2778305200 @default.
• W2108144416 hasConceptScore W2108144416C2780225316 @default.
• W2108144416 hasConceptScore W2108144416C2780401358 @default.
• W2108144416 hasConceptScore W2108144416C535046627 @default.
• W2108144416 hasConceptScore W2108144416C55493867 @default.
• W2108144416 hasConceptScore W2108144416C64927066 @default.
• W2108144416 hasConceptScore W2108144416C71924100 @default.
• W2108144416 hasConceptScore W2108144416C98274493 @default.

• next